Home › Funds › Cambridge Investment Research Advisors, Inc. › ABBV

Cambridge Investment Research Advisors, Inc. position in ABBV

ABBVIE INC · Health Care

Cambridge Investment Research Advisors, Inc. reported holding 565,400 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$147.9M, representing 0.33% of its reported portfolio and ranking #47 among its reported holdings. Cambridge Investment Research Advisors, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)565.40K sh
Reported value held$147.90M
Portfolio Weight0.33%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Cambridge Investment Research Advisors, Inc.'s ABBV position evolved

Cambridge Investment Research Advisors, Inc. first disclosed a stake in ABBV in Q3 2023 at 532,728 shares (US$79.4M). The position peaked in Q3 2026 at 565,400 shares, worth US$147.9M. Across 13 filings, Cambridge Investment Research Advisors, Inc. increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 565,400 shares valued at US$147.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 532.73K $79.41M New
Q4 2023 487.74K $75.58M Reduce
Q1 2024 479.21K $87.26M Reduce
Q2 2024 477.27K $81.86M Hold
Q3 2024 495.07K $97.77M Add
Q4 2024 489.81K $87.04M Reduce
Q1 2025 511.06K $107.08M Add
Q2 2025 521.79K $96.86M Add
Q3 2025 535.46K $123.98M Add
Q4 2025 545.22K $124.58M Add
Q1 2026 552.32K $120.12M Add
Q2 2026 566.38K $142.52M Add
Q3 2026 565.40K $147.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Cambridge Investment Research Advisors, Inc. held ABBV?

Cambridge Investment Research Advisors, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cambridge Investment Research Advisors, Inc.'s current position in ABBV?

As of Q3 2026, Cambridge Investment Research Advisors, Inc. holds 565.40K shares of ABBV (ABBVIE INC), valued at $147.90M, representing 0.33% of its reported portfolio and ranking #47.

Has Cambridge Investment Research Advisors, Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Cambridge Investment Research Advisors, Inc. held unchanged its position in ABBV. The position peaked in Q3 2026 at 565.40K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.